Literature DB >> 2060727

Transplantation of purified islet cells in diabetic rats. I. Standardization of islet cell grafts.

D G Pipeleers1, M Pipeleers-Marichal, J C Hannaert, M Berghmans, P A In't Veld, J Rozing, M Van de Winkel, W Gepts.   

Abstract

A standardized procedure was developed for the preparation of rat islet cell grafts with selected cell number and composition. After collagenase digestion of pancreases and elutriation of tissue fragments, islets were isolated and dissociated, and cells were purified by autofluorescence-activated cell sorting. Approximately 30% of the initial beta-cell mass was lost during digestion and elimination of small mostly exocrine particles. Fifty percent was recovered in isolated islet preparations and 30% in the purified beta-cell suspensions of greater than 95% purity and viability. Sorting according to cellular flavin adenine dinucleotide content discriminated islet beta-cells from islet endocrine non-beta-cells, fibroblasts, leukocytes, and exocrine cells. Purified endocrine islet cell grafts were prepared by aggregating 10(6) pure beta-cells with or without 8 x 10(5) pure endocrine non-beta-cells. In contrast to intact islets, the purified aggregates were devoid of nonendocrine and damaged cells. Intraportal implantation of a pure beta-cell graft rapidly and permanently normalized the diabetic state of streptozocin-administered animals. The standardized preparation of purified beta-cell grafts allows us to address several metabolic and immunological questions concerning islet cell transplantation in diabetes.

Entities:  

Mesh:

Year:  1991        PMID: 2060727     DOI: 10.2337/diab.40.7.908

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats.

Authors:  B Keymeulen; H Teng; M Vetri; F Gorus; P In't Veld; D G Pipeleers
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult rat pancreas.

Authors:  M Chintinne; G Stangé; B Denys; P In 't Veld; K Hellemans; M Pipeleers-Marichal; Z Ling; D Pipeleers
Journal:  Diabetologia       Date:  2010-07-20       Impact factor: 10.122

3.  Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.

Authors:  Bart Keymeulen; Pieter Gillard; Chantal Mathieu; Babak Movahedi; Geert Maleux; Georges Delvaux; Dirk Ysebaert; Bart Roep; Evy Vandemeulebroucke; Miriam Marichal; Peter In 't Veld; Marika Bogdani; Christel Hendrieckx; Frans Gorus; Zhidong Ling; Jon van Rood; Daniel Pipeleers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

4.  Large scale isolation, growth, and function of porcine neonatal islet cells.

Authors:  G S Korbutt; J F Elliott; Z Ao; D K Smith; G L Warnock; R V Rajotte
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

5.  Beta cells are important for islet innervation: evidence from purified rat islet-cell grafts.

Authors:  U Myrsén; B Keymeulen; D G Pipeleers; F Sundler
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

6.  Isolation and purification of rat islet cells by flow cytometry.

Authors:  Azim Akbarzadeh; Dariush Norouzian; Ali Farhangi; Mohammad Reza Mehrabi; Shirin Jamshidi; Davood Zare; Morvarid Shafiei
Journal:  Indian J Clin Biochem       Date:  2008-03-06

Review 7.  Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.

Authors:  Ira J Fox; George Q Daley; Steven A Goldman; Johnny Huard; Timothy J Kamp; Massimo Trucco
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

8.  Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes.

Authors:  V Coppens; Y Heremans; G Leuckx; K Suenens; D Jacobs-Tulleneers-Thevissen; K Verdonck; T Lahoutte; A Luttun; H Heimberg; N De Leu
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

9.  Reversal of hyperglycemia in diabetic mice by a marginal islet mass together with human blood outgrowth endothelial cells is independent of the delivery technique and blood clot-induced processes.

Authors:  Violette Coppens; Yves Heremans; Gunter Leuckx; Krista Suenens; Daniel Jacobs-Tulleneers-Thevissen; Kristoff Verdonck; Aernout Luttun; Harry Heimberg; Nico De Leu
Journal:  Islets       Date:  2013-11-08       Impact factor: 2.694

10.  Treatment of diabetes by transplantation of drug-inducible insulin-producing gut cells.

Authors:  Suraj Unniappan; Rhonda D Wideman; Christine Donald; Virginia Gunn; Jennifer L Wall; Qiu-Xia Zhang; Travis D Webber; Anthony T Cheung; Timothy J Kieffer
Journal:  J Mol Med (Berl)       Date:  2009-04-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.